Scientists have shown how manipulating a novel target in the brain using gene therapy could lead to new treatments for depression. Decreasing a set of proteins in the hippocampus reduced depression-like behavior in mice. If replicated in humans, the findings could inform fresh therapies for millions of patients who do not respond to existing treatments for depression.